Jolt Health to issue 6.36 million shares for debt

Mr. Gerald Tritt reports JOLT HEALTH INC. ANNOUNCES DEBT SETTLEMENT Jolt Health Inc. and arm's-length third parties and related parties have reached debt settlement agreements, whereby the company will issue 6,364,377 common shares at a price of 10 cents per share for a total of $636,437.70, subject to a four-month restricted hold and subject to exchange approval. Related parties transactions account for 732,174 of the shares to be issued will be to two directors and officers, making this a related party transaction. The company is relying upon exemptions contained in sections 5.5(a) and 5.7 (a) of Multilateral Instrument 61-101 as the fair market value of the shares being issued to insiders is less than 25 per cent of the market capitalization of the company. About Jolt Health Inc. Jolt Health is a leading life sciences company focused on health care, biotechnology and artificial intelligence. The company currently holds exclusive licences for innovative therapeutic and pharmaceutical products throughout Europe, the United Kingdom and North America. The company is committed to transforming the industry through research, collaboration and technological advancement, sharping the future of health care worldwide. We seek Safe Harbor.